Frenova Expands to Include a Global Footprint
Frenova Renal Research’s scope has expanded to include a global footprint. Before this expansion, Frenova primarily served clinical researchers in…
Frenova Renal Research Adds to Roster of Managed Clinical Research Sites
Expands Number of Managed Sites for Fast Clinical Trial Enrollment Frenova Renal Research, a division of Fresenius Medical Care North America (FMCNA)…
Frenova Renal Research Adds Fifth Practice to its Site Management Organization (SMO) Business
New Site Expands F1RST Up® Alliance, Increasing Volume of Patients Eligible for Clinical Trial Enrollment Frenova Renal Research, a division…
Frenova Investigator Goes Far To Give Back
Frenova’s F1RST Up® investigators are known for their passion for patients, expertise and research performance. Our investigator partners regularly go…
FDA Broadens ClearGuard HD Antimicrobial Barrier Cap Indications
Fresenius Medical Care continues to set the benchmark for excellence in Australian dialysis clinics
Reducing Risks of Flu for People with ESRD
A New Role in Quality Care: Q&A with Dr. Ahmad Sharif
Frenova Renal Research Announces Expansion of F1RST Up™ (Frenova Rapid STart Up) Alliance of Investigative Sites Designed to Speed Clinical Trial Initiation
Membership Climbs to 55 Renal Investigators Representing 23 Research Sites Frenova Renal Research, the world’s only drug and medical device…
Frenova Enhances Service Offering Through Collaboration Agreement with Leading Global Contract Research Organization, PPD
Alliance Expands PPD’s Access To World-Leading Network of Frenova Researchers and Nephrology Experts Frenova Renal Research, the world’s only drug…